What amount sold does HealthWarehouse.com, Inc. report in Form D filings?

The latest linked filings report $20.7M sold across 7 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was HealthWarehouse.com, Inc.'s most recent SEC filing?

HealthWarehouse.com, Inc.'s most recent Form D filing was on 2020-04-23.

How many investors does HealthWarehouse.com, Inc. have?

The most recent Form D filing lists 11 investor(s).

What type of securities does HealthWarehouse.com, Inc. offer?

HealthWarehouse.com, Inc.'s SEC Form D filings indicate debt offerings.

HealthWarehouse.com, Inc.

CIK: 0000754813·Pharmaceuticals·FLORENCE, KY·Corporation

Reported Sold

$20,670,401

Total Filings

Identified Offerings

Last Filed

Apr 23, 2020

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Apr 23, 2020Form D/A — Amendment

Reported sold: $2,200,000 · Target: $3,000,000

Rule 506(b)·11 investors

Changed: Reported amount sold, Reported investors

Feb 14, 2020Form D — New notice

Reported sold: $1,675,000 · Target: $3,000,000

Rule 506(b)·6 investors

Oct 31, 2014Form D/A — Amendment

Reported sold: $1,653,000 · Target: $2,000,000

Rule 506(b)·14 investors

Changed: Reported amount sold, Reported investors, Sales commissions

Aug 26, 2014Form D — New notice

Reported sold: $1,303,000 · Target: $2,000,000

Rule 506(b)·11 investors

Oct 18, 2011Form D — New notice

Reported sold: $1,500,000 · Target: $1,500,000

Rule 506·3 investors

Sep 14, 2011Form D — New notice

Reported sold: $3,000,000 · Target: $3,000,000

Rule 506·2 investors

Aug 11, 2011Form D — New notice

Reported sold: $1,500,000 · Target: $1,500,000

Rule 506·3 investors

Nov 17, 2010Form D — New notice

Reported sold: $4,301,758 · Target: $4,301,758

Rule 506·4 investors

May 29, 2009Form D — New notice

Reported sold: $6,515,643 · Target: $6,515,643

Rule 506·49 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

$5,000,001 - $25,000,000

Reported commissions across identified offerings

$291,105

Amendment Rate

22%

Latest reported sold across 7 identified offerings

$20,670,401

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Youssef Bennani

Related Person

Appears on 5 filings

Lalit Dhadphale

Related Person

Appears on 5 filings

Patrick E. Delaney

Related Person

Appears on 3 filings

John Backus

Related Person

Appears on 3 filings

Matthew Stecker

Related Person

Appears on 3 filings

Joseph Savarino

Related Person

Appears on 3 filings

Daniel J Seliga

Related Person

Appears on 2 filings

Joseph B Peters

Related Person

Appears on 2 filings

Filing History

Date	Type	Offering target	Reported sold	Investors
Apr 23, 2020	Amendment	$3,000,000	$2,200,000	11
Feb 14, 2020	New	$3,000,000	$1,675,000	6
Oct 31, 2014	Amendment	$2,000,000	$1,653,000	14
Aug 26, 2014	New	$2,000,000	$1,303,000	11
Oct 18, 2011	New	$1,500,000	$1,500,000	3
Sep 14, 2011	New	$3,000,000	$3,000,000	2
Aug 11, 2011	New	$1,500,000	$1,500,000	3
Nov 17, 2010	New	$4,301,758	$4,301,758	4
May 29, 2009	New	$6,515,643	$6,515,643	49

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Telemachus Therapeutics, Inc.

Pharmaceuticals

Offering target: $1,500,000

Filed Oct 28, 2026